Semaglutide Research Overview

Research Use Only. Semaglutide is provided FOR RESEARCH USE ONLY by Core Research Peptides. This compound is intended exclusively for laboratory research, in vitro studies, and preclinical research applications. No medical, therapeutic, health, or clinical claims are applicable. All users must comply with federal, state, and local regulations regarding research chemical handling.

What is Semaglutide?

Semaglutide is a 31-amino acid glucagon-like peptide-1 (GLP-1) receptor agonist with the CAS number 910463-68-2. As a engineered peptide analog, Semaglutide is extensively studied in preclinical research and clinical trial contexts for its mechanisms of action on glucose homeostasis and metabolic signaling pathways.

Chemical and Structural Properties

Semaglutide is a synthetic analog of the naturally occurring GLP-1 peptide hormone. The compound maintains the basic GLP-1 receptor-binding structure while incorporating modifications that enhance stability and bioavailability in research models. The peptide structure allows interaction with specific GLP-1 receptors studied in in vitro cell-based assays and preclinical animal models.

Research Background and Published Studies

Semaglutide is one of the most extensively studied peptide therapeutics in modern pharmaceutical research. Published research in high-impact peer-reviewed journals examines Semaglutide’s molecular mechanisms across multiple research contexts:

• Glucose Homeostasis Research: Preclinical and clinical studies explore Semaglutide’s effects on insulin secretion and blood glucose regulation in controlled conditions.
• GLP-1 Receptor Signaling: In vitro research examines Semaglutide’s binding affinity and activation of GLP-1 receptors on pancreatic, gastrointestinal, and neural tissues.
• Metabolic Effects in Animal Models: Preclinical animal studies investigate Semaglutide’s effects on metabolism, energy expenditure, and weight dynamics.
• Cardiovascular Research: Clinical and preclinical studies examine potential cardiovascular effects of GLP-1 receptor activation.
• Neuroendocrine Mechanisms: Research explores Semaglutide’s interactions with central and peripheral nervous system signaling.

Researchers access published Semaglutide literature through PubMed, clinical trial databases, and peer-reviewed pharmaceutical journals documenting mechanistic and efficacy data.

Available Forms at Core Research Peptides

Core Research Peptides supplies Semaglutide in research-grade lyophilized (freeze-dried) powder form for laboratory and preclinical research. The product is provided with:

• Janoshik Analytical Certificate of Analysis documenting purity and identity
• Complete molecular weight and CAS number (910463-68-2) specifications
• Detailed storage and reconstitution protocols for laboratory use
• Research-use-only compliance documentation

Visit coreresearchpeptides.com to view current Semaglutide product specifications, batch availability, and pricing.

Storage Conditions

Semaglutide lyophilized powder should be stored at room temperature (15–25°C / 59–77°F) in a dry, light-protected environment. Typical shelf life for properly stored lyophilized Semaglutide is 2–3 years when maintained in sealed containers. Once reconstituted in appropriate research-grade solvents, Semaglutide should be refrigerated at 2–8°C (36–46°F) and used within the timeframe specified in product documentation.

Purity and Quality Assurance

Core Research Peptides verifies Semaglutide purity through Janoshik Analytical testing. Certificates published for this compound document:

• HPLC Chromatography: Quantifies Semaglutide purity percentage and identifies impurities
• Mass Spectrometry (MS): Confirms molecular weight and structural identity
• Batch Authentication: Lot number, synthesis date, and analytical testing date

The Janoshik Certificate of Analysis is published on the product page at coreresearchpeptides.com, enabling researchers to verify quality specifications prior to purchase.

Semaglutide in Research: Frequently Asked Questions

Q: What is the CAS number for Semaglutide?

A: Semaglutide has CAS Registry Number 910463-68-2, which uniquely identifies the 31-amino acid GLP-1 receptor agonist structure.

Q: Is Semaglutide from Core Research Peptides third-party tested?

A: Yes. The Semaglutide we stock ships with Janoshik verification and a published Certificate of Analysis documenting purity, molecular identity, and batch specifications on the product page.

Q: What research contexts is Semaglutide appropriate for?

A: Semaglutide is used in preclinical research, in vitro receptor assays, and animal model studies examining GLP-1 signaling, metabolic mechanisms, and peptide pharmacodynamics in controlled laboratory settings.

Q: How should Semaglutide be stored?

A: Store Semaglutide lyophilized powder at room temperature (15–25°C) in a dry, light-protected container. Once reconstituted, store at 2–8°C. Detailed storage instructions are provided with each product.

Q: How do I order Semaglutide for research?

A: Visit coreresearchpeptides.com, navigate to the Semaglutide product page, review the specifications and COA, and place an order for your research institution. Compliance documentation is included with all shipments.

RESEARCH USE ONLY DISCLAIMER: Semaglutide is provided exclusively for research purposes in laboratory, in vitro, and preclinical animal model settings. This product is not intended for human consumption, clinical use, therapeutic application, or any non-research use. Users must comply with all federal, state, and local regulations and institutional guidelines.